Our ambition : regenerate and cure
A multidisciplinary team that pools its skills to pave the way for success.
Management team
Matthieu
DE KALBERMATTEN
General Manager
...
20 years of experience in executive management, corporate strategy, business development and sales, for medtech company and large multinationals.
Ibon
GARITAONANDIA
CSO
...
15 years of experience in stem cell research and regenerative medicine, including Translational Research at a Californian clinical stage biotechnology company developing stem cell-based therapies
Didier
HAGUENAUER
CMODSO
...
Didier has more than 30 years of extensive international experience in clinical development, clinical research and medical affairs from various companies, including AstraZeneca and Biotechs involved in cell therapy. Didier graduated as a Medical Doctor from the University of Paris and holds a Business Administration degree from ESSEC France.
Olivier
FRIEDRICH
CFO
...
15 years of experience in corporate finance, internal control, accounting and tax matters. Senior Manager at EY leading legal financial audits as well as due diligence transactions. CFO of a listed company on Euronext
Jean-Olivier
HIRSCH
COO
...
15 years of experience in the pharmaceutical industry, as director of pharmaceutical affairs, head of quality management and qualified person.
Board of Directors
An optimal mix between successful entrepreneurs and Pharma experts:
President of the board / Shareholder of CellProthera
- Co-founder of Cellprothera and shareholders.
- Chairman and CEO of Zuber-Laederich, a family-owned company that manages industrial and financial assets and has been active for 25 years as a developer of industrial sites undergoing conversion in France.
- Chairman of Dollfus et Muller, a manufacturer of conveyor belts and technical felts for the textile and tanning industries since 1811.
- Tuffier Ravier PY, Trader in Paris and Luxemburg.
Board member / Shareholder of CellProthera
- Founder of Cellprothera.
- MD – Former Head of the Hematology Department – Mulhouse Hospital.
- Légion of Honor award.
Board member / Shareholder of CellProthera
- Co-founder of SAB, a publisher of banking software and managing director for 30 years.
- Director of Business Angel Paris, Investor in >15 start-ups
Board member / Shareholder of CellProthera
- Chairman and co-founder of Addmedica (sold to Merieux)
- CFO of OTL Pharma
- Director of Economic Affairs, Pfizer
Board member / Independant member
- Executive VP and COO of Cellectis
- Ind. Director at TreeFrog, GenSight Biologics, Metafora Biosystems, Inpart, FTI Consulting.
- BCG Partner and managing director.
Board member / Independant member
- Founder of Aloe PE Investment fund.
- Co-founder of PepKon (peptides).
- Board member Allogenica, Polygon.
- CEO Numericable
MD, PhD, Board member / Independant member
- EVP and CMO at Ipsen.
- Adjunct professor of medicine, university of Freiburg
- Board certified in cardiology.
Scientific Advisory Board
Prof. Deepak BHATT*
- Director of the Mount Sinai Fuster Heart Hospital, NY, USA
- Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai Health System
- Former Director of Interventional Cardiovascular Programs at Harvard
Prof. Cesario BORLONGAN
- Vice-Chairman of Research USF Morsani College of Medicine
- Director of Center of Excellence for Aging and Brain Repair, USF Health, Tampa FL – USA
Prof. Javed BUTLER
- President of the Baylor Scott and White Research Institute
- Distinguished Professor of Medicine at University of Mississipi in Jackson, MS – USA
Prof. Timothy HENRY
- Medical Director, The Carl and Edyth Lindner Center for Research and Education
- The Carl and Edyth Lindner Family Distinguished Chair in Clinical Research, OH – USA
Prof. Jeanne LORING
- Director of the Center for Regenerative Medicine, The Scripps Research Institute, La Jolla, CA – USA
- Founder of Aspen Neuroscience
Prof. Pierre-Yves MARIE*
- Head of Nuclear Medicine Department at Nancy University Hospital – France
- Scientific Director of Nancylcotep
Prof. Gilles MONTALESCOT*
- Head of the Department of Cardiology at the Institute of Cardiology
- Hôpital de la Pitié-Salpétrière, Paris – France
Prof. Guilio POMPILIO
- Professor at the Department of Biomedical, Surgical, and Dental Sciences, University degli Studi di Milano
- Monzino Cardiology Center, University Hospital Milano – Italy
Prof. Jérôme RONCALLI*
- Director of the Heart Failure Unit in the Department of Cardiology at the University Hospital of Toulouse – France.
- Vice-President of the French Federation of Cardiology
Prof. Denis-Claude ROY
- Director of the Centre of Excellence for Cellular Therapy
- Founder and Executive Director of CellCAN University of Montreal Montreal – Canada
Prof. Scott SOLOMON*
- Distinguished Chair, Professor of Medicine at Harvard Medical School and Brigham and Women’s Hospital
- Director, Clinical Trials Outcomes Center, Harvard Medical School, Boston, MA – USA
Prof. Faiez ZANNAD*
- Emeritus Professor of Therapeutics at the University of Lorraine – France
- University of Lorraine, INSERM, CHRU Nancy, Multidisciplinary Clinical Investigation Center (CIC-P 1433)
Founders
The good results of the Proof of Concept Trial led both Philippe HENON and Jean-Claude JELSCH to found CellProthera in 2008 whose objectives are to develop and bring to patients this innovative therapeutic solution.
At the origin of the therapeutic solution, Prof. Philippe HENON, MD – Head of the Hematology Department – Mulhouse Hospitals, is one of the pioneers in the field of peripheral blood stem cell (PBSC) identification and transplantation and performed the 6th peripheral blood stem cell transplantation in the world in 1986…
...
Jean-Claude JELSCH (†2022) was for over 30 years, an esteemed member of ADECCO top management. After he co-founded Cardinal Development, a capital development company in Alsace, he became Chairman of IRHT…
...
QMS & Regulatory Affairs
